AI Analysis AI Analysis of IMUX AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add IMUX to Watchlist?
Some Reasons Why To Add IMUX:
  • +97.2% price growth over the last year
  • +143.6% YTD performance
  • Bullish trend confirmed on both short and long timeframes
PDF

Red day on Thursday for Immunic Inc.
(Updated on Jun 18, 2026)

Buy candidate since Jun 11, 2026 Gain 8.65%

No changes to the price of Immunic Inc. stock on the last trading day (Thursday, 18th Jun 2026). During the last trading day the stock fluctuated 5.36% from a day low at $13.71 to a day high of $14.45. The price has risen in 5 of the last 10 days but is still down by -1.59% for this period.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 23.00% during the next 3 months and, with a 90% probability hold a price between $13.01 and $19.36 at the end of this 3-month period.

IMUX Signals & Forecast

The Immunic Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $13.54 and $12.70. A breakdown below any of these levels will issue sell signals. The volume rose on the last day while price remained unchanged. This may be an early warning and the stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, June 17, 2026, and so far it has fallen 0%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Immunic Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $11.70 and $11.10. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Immunic Inc. finds support just below today's level at $11.70. If this is broken, then the next support from accumulated volume will be at $11.10 and $11.02.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.735 between high and low, or 5.36%. For the last week, the stock has had daily average volatility of 7.05%.

Our recommended stop-loss: $13.62 (-4.10%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (IMUX) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect Immunic Inc. to open at $14.12, and during the day (based on 14 day Average True Range), to move between $13.64 and $14.76, which gives a possible trading interval of +/-$1.12 (+/-8.18%) up or down from last closing price. If Immunic Inc. takes out the full calculated possible swing range there will be an estimated 8.18% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $14.64 (3.10%) than the support at $11.70 (17.61%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Immunic Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Immunic Inc. stock to perform well in the short-term.

Current score: 2.967 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 22, 2026 - $14.12 ( 0.575%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

IMUX Performance

Trading levels for IMUX

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 14.85 4.60%
R2 14.57 2.62%
R1 14.40 1.40%
Price 14.20
S1 13.84 -2.55%
S2 13.66 -3.77%
S3 13.38 -5.75%

Accumulated Volume Support & Resistance Levels

Level Price
R3 14.97 5.42%
R2 14.96 5.35%
R1 14.64 3.10%
Price 14.20
S1 11.70 -17.61%
S2 11.10 -21.83%
S3 11.02 -22.39%

FAQ

What is the symbol for Immunic Inc. Stock and on which exchange is it traded?
The symbol for Immunic Inc. is IMUX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Immunic Inc. Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Immunic Inc. stock to perform well in the short-term.

How to buy Immunic Inc. Stock?
Immunic Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Immunic Inc. Stock.

What's the current price of Immunic Inc. Stock?
As of the end of day on the Jun 18, 2026, the price of an Immunic Inc. (IMUX) share was $14.20.

What is the 52-week high and low for Immunic Inc. Stock?
The 52-week high for Immunic Inc. Stock is $15.77 and the 52-week low is $5.06.

What is the market capitalization of Immunic Inc. Stock?
As of the Jun 18, 2026, the market capitalization of Immunic Inc. is 140.133M.

When is the next earnings date for Immunic Inc.?
The upcoming earnings date for Immunic Inc. is Aug 06, 2026.
Click to get the best stock tips daily for free!
ABOUT IMMUNIC INC.
Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and other chronic inflammatory and autoimmune diseases, as well as to treat coronavirus disease. The company i...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
7.76% Jun 12
DHI
$146.71
7.57% Jun 10
PHM
$118.49
7.15% Jun 10
EAT
$140.46
17.39% Jun 05
TPR
$140.47
2.16% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE